Krystal Biotech, Inc.
DE ˙ DB ˙ US5011471027
257,90 € ↓ -1,10 (-0,42%)
2026-06-04
DEL PRIS
SecurityDE:4KB / Krystal Biotech, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership31,172 shares
Latest Disclosed Value $ 8,052,351
Citigroup Inc ownership in 4KB / Krystal Biotech, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 31,172 shares of Krystal Biotech, Inc. (DE:4KB) valued at $6,708,214 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 29,943 shares of Krystal Biotech, Inc.. This represents a change in shares of 4.10% during the quarter. The current value of the position is $8,039,259 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (4KB) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:4KB / Krystal Biotech, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F KRYSTAL BIOTECH COM 501147102 31,172 1,229 4.10 8,052 9.08 0.0017
2026-02-13 2025-12-31 13F KRYSTAL BIOTECH COM 501147102 29,943 20,293 210.29 7,382 333.47 0.0033
2025-11-10 2025-09-30 13F KRYSTAL BIOTECH COM 501147102 9,650 -42,883 -81.63 1,704 -76.42 0.0008
2025-08-11 2025-06-30 13F KRYSTAL BIOTECH COM 501147102 52,533 -20,992 -28.55 7,221 -45.53 0.0035
2025-05-12 2025-03-31 13F KRYSTAL BIOTECH COM 501147102 73,525 -26,108 -26.20 13,257 -15.07 0.0068
2025-02-12 2024-12-31 13F KRYSTAL BIOTECH COM 501147102 99,633 64,549 183.98 15,609 144.41 0.0093
2024-11-12 2024-09-30 13F KRYSTAL BIOTECH COM 501147102 35,084 13,874 65.41 6,386 63.95 0.0037
2024-08-12 2024-06-30 13F KRYSTAL BIOTECH COM 501147102 21,210 -30,908 -59.30 3,895 -58.00 0.0025
2024-05-10 2024-03-31 13F KRYSTAL BIOTECH COM 501147102 52,118 15,552 42.53 9,273 104.43 0.0061
2024-02-09 2023-12-31 13F KRYSTAL BIOTECH COM 501147102 36,566 779 2.18 4,536 9.27 0.0032
2023-12-06 2023-09-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 35,787 13,423 60.02 4,151 58.13 0.0031
2023-11-09 2023-09-30 13F KRYSTAL BIOTECH COM 501147102 35,787 13,423 4,151 0.0012
2023-08-10 2023-06-30 13F KRYSTAL BIOTECH COM 501147102 22,364 -28,221 -55.79 2,626 -35.17 0.0017
2023-05-11 2023-03-31 13F KRYSTAL BIOTECH COM 501147102 50,585 21,825 75.89 4,050 77.74 0.0028
2023-02-09 2022-12-31 13F KRYSTAL BIOTECH COM 501147102 28,760 -21,063 -42.28 2,278 -34.39 0.0018
2022-11-10 2022-09-30 13F KRYSTAL BIOTECH COM 501147102 49,823 12,806 34.59 3,472 42.88 0.0025
2022-08-10 2022-06-30 13F KRYSTAL BIOTECH COM 501147102 37,017 21,785 143.02 2,430 139.64 0.0018
2022-05-12 2022-03-31 13F KRYSTAL BIOTECH COM 501147102 15,232 -19,656 -56.34 1,014 -58.44 0.0006
2022-02-10 2021-12-31 13F KRYSTAL BIOTECH COM 501147102 34,888 4,926 16.44 2,440 56.01 0.0013
2021-11-10 2021-09-30 13F KRYSTAL BIOTECH COM 501147102 29,962 -19,413 -39.32 1,564 -53.42 0.0009
2021-08-10 2021-06-30 13F KRYSTAL BIOTECH COM 501147102 49,375 10,456 26.87 3,358 12.01 0.0020
2021-05-13 2021-03-31 13F KRYSTAL BIOTECH COM 501147102 38,919 17,244 79.56 2,998 130.62 0.0019
2021-02-11 2020-12-31 13F KRYSTAL BIOTECH COM 501147102 21,675 19,943 1,151.44 1,300 1,633.33 0.0008
2020-11-12 2020-09-30 13F KRYSTAL BIOTECH COM 501147102 1,732 -32,489 -94.94 75 -94.71 0.0000
2020-08-12 2020-06-30 13F KRYSTAL BIOTECH COM 501147102 34,221 -25,488 -42.69 1,418 -45.08 0.0011
2020-05-12 2020-03-31 13F KRYSTAL BIOTECH COM 501147102 59,709 -1,060 -1.74 2,582 -23.29 0.0023
2020-02-12 2019-12-31 13F KRYSTAL BIOTECH COM 501147102 60,769 46,937 339.34 3,366 599.79 0.0024
2019-11-08 2019-09-30 13F KRYSTAL BIOTECH COM 501147102 13,832 11,377 463.42 481 385.86 0.0004
2019-08-12 2019-06-30 13F KRYSTAL BIOTECH COM 501147102 2,455 -19,659 -88.90 99 -86.40 0.0001
2019-05-13 2019-03-31 13F KRYSTAL BIOTECH COM 501147102 22,114 11,811 114.64 728 240.19 0.0007
2019-02-12 2018-12-31 13F KRYSTAL BIOTECH COM 501147102 10,303 10,303 214 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-13 2025-12-31 13F KRYSTAL BIOTECH COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-10 2025-09-30 13F KRYSTAL BIOTECH COM Call 200 -98.89 35 -98.59 n/a n/a n/a
2025-08-11 2025-06-30 13F KRYSTAL BIOTECH COM Call 18,000 0.00 2,474 -23.76 n/a n/a n/a
2025-05-12 2025-03-31 13F KRYSTAL BIOTECH COM Call 18,000 -10.00 3,245 3.57 n/a n/a n/a
2025-02-12 2024-12-31 13F KRYSTAL BIOTECH COM Call 20,000 3,133 n/a n/a n/a
2024-02-09 2023-12-31 13F KRYSTAL BIOTECH COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-12-06 2023-09-30 13F/A KRYSTAL BIOTECH COM Call 12,400 1,438 n/a n/a n/a
2023-11-09 2023-09-30 13F KRYSTAL BIOTECH COM Call 12,400 1,438 n/a n/a n/a
2023-08-10 2023-06-30 13F KRYSTAL BIOTECH COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-11 2023-03-31 13F KRYSTAL BIOTECH COM Call 8,300 664 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-13 2025-12-31 13F KRYSTAL BIOTECH COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-10 2025-09-30 13F KRYSTAL BIOTECH COM Put 200 -98.89 35 -98.59 n/a n/a n/a
2025-08-11 2025-06-30 13F KRYSTAL BIOTECH COM Put 18,000 0.00 2,474 -23.76 n/a n/a n/a
2025-05-12 2025-03-31 13F KRYSTAL BIOTECH COM Put 18,000 -10.00 3,245 3.57 n/a n/a n/a
2025-02-12 2024-12-31 13F KRYSTAL BIOTECH COM Put 20,000 3,133 n/a n/a n/a
2024-02-09 2023-12-31 13F KRYSTAL BIOTECH COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-12-06 2023-09-30 13F/A KRYSTAL BIOTECH COM Put 12,400 1,438 n/a n/a n/a
2023-11-09 2023-09-30 13F KRYSTAL BIOTECH COM Put 12,400 1,438 n/a n/a n/a
2023-08-10 2023-06-30 13F KRYSTAL BIOTECH COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-11 2023-03-31 13F KRYSTAL BIOTECH COM Put 8,300 664 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.